Status: current, Defined. Date: 31-Aug 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 242241000036112 | OP-1 (osteogenic protein-1 3.3 mg) implant, 3.3 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 242251000036110 | OP-1 3.3 mg implant, 3.3 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| OP-1 3.3 mg implant, 3.3 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| OP-1 3.3 mg implant, 3.3 mg vial | Is a | OP-1 | true | Inferred relationship | Some | ||
| OP-1 3.3 mg implant, 3.3 mg vial | Is a | osteogenic protein-1 3.3 mg implant, vial | true | Inferred relationship | Some | ||
| OP-1 3.3 mg implant, 3.3 mg vial | has Australian BoSS | osteogenic protein-1 | true | Inferred relationship | Some | 398734598 | |
| OP-1 3.3 mg implant, 3.3 mg vial | has unit of use | vial | true | Inferred relationship | Some | 398734599 | |
| OP-1 3.3 mg implant, 3.3 mg vial | has manufactured dose form | implant | true | Inferred relationship | Some | ||
| OP-1 3.3 mg implant, 3.3 mg vial | has intended active ingredient | osteogenic protein-1 | true | Inferred relationship | Some | 398734598 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| OP-1 3.3 mg implant, 1 vial | has TPUU | True | OP-1 3.3 mg implant, 3.3 mg vial | Inferred relationship | Some | 1 |
| OP-1 3.3 mg implant, 1 vial | has TPUU | True | OP-1 3.3 mg implant, 3.3 mg vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR